Ninevah Therapeutics is a discovery stage biotech focused on bringing novel gene therapies to kidney patients. There are more than 450 rare genetic kidney diseases for which there is no cure. In most cases, patients reach end-stage renal failure and require dialysis and a kidney transplant, which significantly affects their quality of life. We are discovering gene therapies that have the potential to cure these patients.
